Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Mike O. Becker"'
Autor:
Florian Renoux, Mara Stellato, Claudia Haftmann, Alexander Vogetseder, Riyun Huang, Arun Subramaniam, Mike O. Becker, Przemyslaw Blyszczuk, Burkhard Becher, Jörg H.W. Distler, Gabriela Kania, Onur Boyman, Oliver Distler
Publikováno v:
Cell Reports, Vol 31, Iss 13, Pp 107826- (2020)
Summary: Regulatory T cells (Tregs) represent a major population in the control of immune homeostasis and autoimmunity. Here we show that Fos-like 2 (Fosl2), a TCR-induced AP1 transcription factor, represses Treg development and controls autoimmunity
Externí odkaz:
https://doaj.org/article/45ec7e41627d41c48d84b42d55a3820f
Autor:
Mike O Becker, Gunnel Sandqvist, Tore K Kvien, Marco Matucci-Cerinic, Roger Hesselstrand, Patricia Carreira, László Czirják, Rucsandra Dobrota, Cosimo Bruni, Yannick Allanore, Otylia Kowal-Bielecka, Annelise Roennow, A. Garaiman, Christopher P. Denton, Ana Maria Gheorghiu, Rudolf Debelak, Joseph O. Sexton, Carina Mihai, Oliver Distler, Turid Heiberg, Ulf Mueller-Ladner, Ann Tyrrell Kennedy, Kim Fligelstone
ObjectivesPatient-reported outcome measures (PROMs) are important for clinical practice and research. Given the high unmet need, our aim was to develop a comprehensive PROM for systemic sclerosis (SSc), jointly with patient experts.MethodsThis Europe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cc88951f76e0571d33442ea69a4015d
https://www.zora.uzh.ch/id/eprint/210236/
https://www.zora.uzh.ch/id/eprint/210236/
Publikováno v:
Gefässchirurgie. 24:152-161
Die Therapie der Vaskulitiden umfasst heutzutage die gesamte Breite der konventionellen immunsuppressiven Medikamente sowie einzelne Biologika (insbesondere Rituximab). Im Einzelfall wird die medikamentose Therapie bei Patienten mit Befall von mittle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4812c0b2eeb32185f7274a0622a16491
https://doi.org/10.1007/s00772-019-0506-0
https://doi.org/10.1007/s00772-019-0506-0
Publikováno v:
Gefässchirurgie. 24:104-113
Die Vaskulitiden sind (zumeist seltene) entzundliche Gefaserkrankungen mit sehr heterogenem klinischem Erscheinungsbild. Sie konnen akut auftreten und lebensbedrohlich sein und erfordern haufig eine interdisziplinare Zusammenarbeit bei Diagnostik und
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f49ea04c13eaceb36e869f3c15b25848
https://doi.org/10.1007/s00772-018-0499-0
https://doi.org/10.1007/s00772-018-0499-0
Autor:
Frank Ruschitzka, Valery Vishnevskiy, Christian T. Stoeck, Lukas Wissmann, C. Mihai, Britta Maurer, Rucsandra Dobrota, Alexander Gotschy, C von Deuster, Sebastian Kozerke, Oliver Distler, Robert Manka, Mike O Becker, Mareike Gastl, Suzana Jordan
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 22
Funding Acknowledgements Type of funding sources: None. Background - Myocardial involvement is common in patients with systemic sclerosis (SSc) and causes myocardial fibrosis and subtle ventricular dysfunction. However, the temporal onset of myocardi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::454936b263925f9df8b6d576d2f543c7
https://doi.org/10.1093/ehjci/jeab090.057
https://doi.org/10.1093/ehjci/jeab090.057
Autor:
Oliver Distler, Britta Maurer, Mike O Becker, A. Garaiman, Rucsandra Dobrota, Norina Zampatti, Suzana Jordan, Carina Mihai
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-11 (2021)
Arthritis Research & Therapy
Zampatti, Norina; Garaiman, Alexandru; Jordan, Suzana; Dobrota, Rucsandra; Becker, Mike Oliver; Maurer, Britta; Distler, Oliver; Mihai, Carina (2021). Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis. Arthritis research & therapy, 23(1), p. 125. BioMed Central 10.1186/s13075-021-02506-x
Arthritis Research & Therapy
Zampatti, Norina; Garaiman, Alexandru; Jordan, Suzana; Dobrota, Rucsandra; Becker, Mike Oliver; Maurer, Britta; Distler, Oliver; Mihai, Carina (2021). Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis. Arthritis research & therapy, 23(1), p. 125. BioMed Central 10.1186/s13075-021-02506-x
Background and objectives The University of California Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0 (UCLA GIT 2.0) is validated to capture gastrointestinal (GI) tract morbidity in patients with systemic scle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12eeba8a15c20d5f71b9814813b66ce1
https://doi.org/10.1186/s13075-021-02506-x
https://doi.org/10.1186/s13075-021-02506-x
Autor:
Britta Maurer, Oliver Distler, Suzana Jordan, C. Mihai, Petra Hoederath, Rucsandra Dobrota, Mike O Becker, Caroline Evers
Publikováno v:
Evers, Caroline; Jordan, Suzana; Maurer, Britta; Becker, Mike Oliver; Mihai, Carina; Dobrota, Rucsandra; Hoederath, Petra; Distler, Oliver (2021). Pain chronification and the important role of non-disease-specific symptoms in patients with systemic sclerosis. Arthritis research & therapy, 23(1), p. 34. BioMed Central 10.1186/s13075-021-02421-1
Arthritis Research & Therapy
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-12 (2021)
Arthritis Research & Therapy
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-12 (2021)
Background Pain is a frequent, yet inadequately explored challenge in patients with systemic sclerosis (SSc). This study aimed to conduct an extensive pain assessment, examining pain chronification and its association with disease manifestations. Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ab3ddf28e4daacd777d1bb0e962f403
https://boris.unibe.ch/161815/1/s13075-021-02421-1.pdf
https://boris.unibe.ch/161815/1/s13075-021-02421-1.pdf
Autor:
Rucsandra Dobrota, Suzana Jordan, Britta Maurer, Elisabeth Blaja, Marco Matucci-Cerinic, Oliver Distler, Mike O Becker, Carmen-Marina Mihai
Objective.To address the hypothesis that very early patients with systemic sclerosis (SSc) are a heterogeneous group with mild or early disease, we analyzed the extent of heterogeneity in clinical, epidemiological, and immunological characteristics o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fedf09a41c9ff81624ff3daa098baf9e
Autor:
Yannick Allanore, Anna-Maria Hoffmann-Vold, Suzana Jordan, Wanlong Wu, Elise Siegert, Britta Maurer, Håvard Fretheim, Oliver Distler, Mike O Becker, Shuang Ye, Rucsandra Dobrota
Publikováno v:
Annals of the Rheumatic Diseases. 77:1326-1332
ObjectivesTo identify the predictive clinical characteristics and establish a prediction model for the progression of mild interstitial lung disease (ILD) in patients with systemic sclerosis (SSc).MethodsPatients with SSc from two independent prospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d78abf9d9e671c65d85845ce3683c03b
https://doi.org/10.1136/annrheumdis-2018-213201
https://doi.org/10.1136/annrheumdis-2018-213201
Autor:
Rucsandra Dobrota, A. Garaiman, Mike O Becker, Britta Maurer, Suzana Jordan, Maria Schröder, Oliver Distler, C. Mihai
Publikováno v:
Annals of the Rheumatic Diseases
During the current global outbreak of coronavirus disease 2019 (COVID-19), risk stratification of patients is of utmost importance. Currently, patients >65 years and those with pre-existing medical conditions such as cardiovascular disease, chronic r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c86ea78d86495dfa8ec9579171babcf
https://doi.org/10.1136/annrheumdis-2020-217442
https://doi.org/10.1136/annrheumdis-2020-217442